Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.78 |
| ▸ | PGD | P52209 | 3/20 | 0.50 |
| ▸ | PGK1 | P00558 | 1/20 | 0.44 |
| ▸ | PGK2 | P07205 | 1/20 | 0.44 |
| ▸ | S1PR4 | O95977 | 2/20 | 0.36 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.36 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.36 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.36 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.36 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9741443 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL850111 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL939515 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9738232 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9736731 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL21609 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL9737704 | 1.00 | MPI (0.78) | MPIPGDPGK1PGK2S1PR4 | |
| Ammonia Solution, Strong SCHEMBL638028 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 | |
| Water SCHEMBL22390105 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 | |
| SCHEMBL10435219 | 0.98 | MPI (0.75) | MPIPGDPGK1PGK2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| WO-2025019764-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | MATTERWORKS INC (US) | 2025-01-23 | — | — | WO | claimed |
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2025-01-16 | — | — | US | claimed |
| EP-4437319-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | Matterworks Inc (US) | 2024-10-02 | — | — | EP | claimed |
| EP-4433077-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL Business Ltd (GB) | 2024-09-25 | — | — | EP | claimed |
| US-12006526-B2 | Microorganisms and methods for the production of oxygenated compounds from hexoses | BRASKEM S.A. (BR) | 2024-06-11 | — | — | US | claimed |
| WO-2023131727-A1 | C-NUCLEOSIDE MONOPHOSPHATE SYNTHESIS | UAB BIOMATTER DESIGNS (LT) | 2023-07-13 | — | — | WO | claimed |
| WO-2023089313-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | UCL BUSINESS LTD (GB) | 2023-05-25 | — | — | WO | claimed |
| WO-2023077166-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC (US) | 2023-05-04 | — | — | WO | claimed |
| US-20230137741-A1 | METHODS AND COMPOSITIONS FOR ANALYTE QUANTIFICATION | MATTERWORKS INC | 2023-05-04 | — | — | US | claimed |
| CN-113710807-A | Microorganisms and methods for producing oxygenates from hexoses | 布拉斯科公司 | 2021-11-26 | — | — | CN | claimed |
| EP-3908663-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES | Braskem S.A. (BR) | 2021-11-17 | — | — | EP | claimed |
| EP-3814515-A2 | ENGINEERED MICROORGANISMS WITH G3P---> 3PG ENZYME AND/OR FRUCTOSE-1,6-BISPHOSPHATASE INCLUDING THOSE HAVING SYNTHETIC OR ENHANCED METHYLOTROPHY | Genomatica, Inc. (US) | 2021-05-05 | — | — | EP | claimed |
| US-20200283806-A1 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF OXYGENATED COMPOUNDS FROM HEXOSES | BRASKEM S.A. (BR) | 2020-09-10 | — | — | US | claimed |
| CN-110819694-A | Enzyme activity reaction determination method of rmpA | 杭州谨澳生物科技有限公司 | 2020-02-21 | — | — | CN | claimed |
| EP-2863863-B1 | REDUCTION OF TOOTH STAINING DERIVED FROM CATIONIC ANTIMICROBIALS | PROCTER & GAMBLE (US) | 2018-05-30 | — | — | EP | claimed |
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | MATTERWORKS INC (US) | 2026-05-28 | — | — | US | disclosed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | disclosed |
| EP-0645962-A1 | METHODS AND COMPOSITIONS FOR ENHANCING CARBON FIXATION IN PLANTS | NONOMURA, Arthur M. (US) | 1995-04-05 | — | — | EP | disclosed |
| WO-1994000009-A1 | METHODS AND COMPOSITIONS FOR ENHANCING CARBON FIXATION IN PLANTS | NONOMURA ARTHUR M (US) | 1994-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260148950-A1 | METHODS AND SYSTEMS FOR PREDICTIVE ANALYSIS BY MASS SPECTROMETRY | SRMS, PTMS, CALCB | MPI 2195/4885PGD 631/4885PGK1 3320/4885 |
| US-20250017950-A1 | COMPOUNDS FOR TREATING MITOCHONDRIAL DNA DISORDERS | POLRMT, TK2, GOT2 | MPI 454/4885PGD 34/4885PGK1 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.